TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
FrostPharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
185,395
|
131,826
|
77,243 |
Financial expenses |
2,997
|
2,003
|
1,867 |
Earnings before taxes |
14,188
|
26,779
|
-5,432 |
EBITDA |
18,539
|
29,424
|
-3,552 |
Total assets |
128,855
|
94,816
|
59,415 |
Current assets |
120,788
|
86,978
|
56,916 |
Current liabilities |
44,300
|
64,061
|
52,950 |
Equity capital |
42,703
|
29,554
|
6,466 |
- share capital |
61
|
55
|
57 |
Employees (average) |
15
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.1%
|
31.2%
|
10.9% |
Turnover per employee |
12,360
|
13,183
|
9,655 |
Profit as a percentage of turnover |
7.7%
|
20.3%
|
-7.0% |
Return on assets (ROA) |
13.3%
|
30.4%
|
-6.0% |
Current ratio |
272.7%
|
135.8%
|
107.5% |
Return on equity (ROE) |
33.2%
|
90.6%
|
-84.0% |
Change turnover |
44,215
|
56,904
|
-81,914 |
Change turnover % |
31%
|
76%
|
-51% |
Chg. No. of employees |
5
|
2
|
3 |
Chg. No. of employees % |
50%
|
25%
|
60% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.